Interest of Preoperative Arteriography to Identify the Adamkiewicz Artery Before Surgery for Basi-thoracic Neuroblastic Tumors

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeUp to 18
SponsorAssistance Publique - Hôpitaux de Paris

About this trial

Neuroblastic tumors (NBTs) develop from neural crest cells that give rise to the sympathetic nervous system. They include neuroblastomas, ganglioneuroblastomas, and ganglioneuromas. They represent approximately 10% of solid tumors in children under 15 years of age. In 15 to 20% of cases, NBTs are located in the thoracic region. These paravertebral tumors have an extracanal component and some also have an intraspinal component (dumbbell tumors) that can cause spinal cord compression. Surgery for these tumors also exposes the patient to neurological complications. In the thorax, the basi-thoracic location (T9-T12) may be particularly at risk due to the presence of the artery of Adamkiewicz (AKA), which supplies blood to the spinal cord; damage to this artery can result in spinal cord ischemia. To avoid this scenario, some teams recommend performing spinal cord arteriography to identify AKA. However, many centers do not perform arteriography and do not report more postoperative complications.

Currently, there is no consensus on the indications for performing preoperative spinal arteriography in patients undergoing surgery for basi-thoracic NBT.

This study evaluates the practice in France of preoperative arteriography to identify the AKA among patients undergoing surgery for basi-thoracic neuroblastic tumors and analyzes the incidence of postoperative neurological complications in these patients.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients undergoing surgery for a neuroblastic tumor (neuroblastoma, ganglioneuroblastoma, ganglioneuroma)

Basithoracic location between T8 and L1

With or without intraspinal component

Treated in a pediatric surgery department in France

Disqualifiers

None

Trial population

Patients undergoing surgery for a neuroblastic tumor in a pediatric surgery department in France between 2005 and 2024 and meeting the inclusion criteria.

Trial design

Design model

Case-only

Time perspective

Retrospective

Treatments tested in this trial

  • Collection of data from the patient's medical file.

    Other intervention

    Collection of data from the patient's medical file.

Treatment groups

150 Participants
are divided into 1 treatment group
Group A: Pediatric patients1 intervention

Trial outcomes

Primary outcomes

1

Occurrence of neurological complications secondary to spinal cord ischemia

Assessment of postoperative neurological complications in patients undergoing surgery for basi-thoracic NBT, with or without preoperative spinal cord arteriography.

Time frame
2005 to 2024

Secondary outcomes

1

Demographic characteristics of patients undergoing surgery for basithoracic neuroblastic tumor

Describe the demographic characteristics of patients undergoing surgery for basithoracic neuroblastic tumor.

Time frame
2005 to 2024
2

Outcome of patients undergoing surgery for basithoracic neuroblastic tumor

Describe the overall survival and recurrence-free survival.

Time frame
2005 to 2024

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Assistance Publique - Hôpitaux de Paris

Lead sponsor

URC-CIC Paris Descartes Necker Cochin

Collaborator

This trial is not recruiting at the moment. You can still explore other options: